Treatment of congenital coagulopathies, from biologic to biotechnological drugs: the relevance of gene editing (CRISPR/Cas) - De Pablo-Moreno, J A; Miguel-Batuecas, A; Rodríguez-Merchán, E C; Liras, A (Thromb Res, 2023)